🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label Phase I study aims to define the recommended dose for furth...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-12
Trial ID
NCT03612739
Treatments Being Tested
The purpose of the alloSHRINK study is to assess the safety, cell kinetics ...
Status
Recruiting
Location
Moffit Cancer Center
Start Date
2018-11-28
Trial ID
NCT03692429
The purpose of the CYAD-101-002 study is to assess the safety and clinical ...
Status
Recruiting
Location
Mayo Clinic
Start Date
2021-11-22
Trial ID
NCT04991948
Treatments Being Tested
The purpose of this study is to test an experimental anti-cancer immunother...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2017-10-11
Trial ID
NCT03370198
Treatments Being Tested
This open-label Phase I study aims at assessing primarily the safety of the...
Status
Completed
Location
University of Colorado
Start Date
2018-09-18
Trial ID
NCT03466320
Treatments Being Tested
THINK (THerapeutic Immunotherapy with NKR-2) is a multinational (EU/US) ope...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT03018405
Treatments Being Tested
SHRINK (Standard cHemotherapy Regimen and Immunotherapy with NKR-2) is an o...
Status
Unknown
Location
Institut Jules Bordet
Start Date
2017-08-07
Trial ID
NCT03310008
Treatments Being Tested
This Phase I clinical trial is evaluating chimeric-antigen receptor (CAR) T...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2015-03
Trial ID
NCT02203825
Treatments Being Tested